心脏肾上腺素能神经的PET应用

王雪梅; 何玉林; 王爽; 吴君; 赵周社

doi:10.3760/cma.j.issn.1673-4114.2009.01.014

心脏肾上腺素能神经的PET应用

王雪梅 , 何玉林 , 王爽 , 吴君 , 赵周社

文章导航 > 国际放射医学核医学杂志 > 2009, 33 > 1: (14-17)

引用本文:

Citation:

心脏肾上腺素能神经的PET应用

1. 内蒙古医学院附属医院核医学科, 呼和浩特 010050;
2. 美国通用电气医疗系统集团(中国), 北京 100176

Application of cardiac neurotransmission PET imaging

1. Nulear Medicine Department, the Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China;
2. Molecule Imaging Modality, GE Healthcare China, Beijing, 100176, China

摘要: 心脏肾上腺素能PET对于鉴别原发性和继发性心脏神经病,以及心肌病治疗效果评价均具有重要价值。主要介绍心脏肾上腺素能神经PET成像原理、所使用正电子显像剂、PET成像方法和临床应用,尤其对心脏。肾上腺素能神经正电子显像剂进展进行重点介绍。
- 心脏 /
- 肾上腺素能神经 /
- 正电子发射断层显像术
Abstract: Cardiac neurotransmission PET with positron tracers is very useful to characterize myocardial neuronal diseases in primary cardioneuropathies or in secondary cardioneuropathies, and to monitor treatments. It mainly introduces the principle, method, tracers and clinical applications with cardiac neurotransmission PET with positron tracers, especially new nonepinephrine tracers.
- Heart /
- Sympathetic nervous system /
- Positron-emission tomography
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Wu JC,Bengel FM,Gam bhir SS.Cardiovascular molecular imaging.Radiology,2007,244(2):337-355.
[2]	Sehwaiger M,Hutchins GD,Kaltt V.Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography.J Clin Invest.1991,87(5):1681-1690.
[3]	Langer O,Haildin C.PET and SPECT tracers for mapping the cardiac nervous system.Eur J Nucl Med Mol Imaging,2002,29(3):416-434.
[4]	Carrio I.Cardiac neurotransmission imaging.J Nucl Med,2001,42(7):1062-1076.
[5]	Caldwell JH,Kroll K.Li Z,et al.Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine.J Nucl Med,1998,39(8):1327-1334.
[6]	Delforge J,Syrota A,Lancon JP,et al.Cardiac beta-adrenergic receptor density measured in vivo using PET,CGP 12177,and a new graphical method.J Nucl Med,1991,32(4):739-748.
[7]	de Jong RM,Willemsen AT,Slart RH,et al.Myocardial betaadrenoceptor downregulation in idiopathic dilated eardiomyopathy measured in vivo with PET using the new radioligand (S)-[¹¹C]CGP12388.Eur J Nucl Med Mol Imaging,2005,32(4):443-447.
[8]	Goldstein DS,Eldadah B,Sharabi Y,et al.Cardiac sympathetic hypa-innervation in familial dysantonomia.Clin Aaron Res,2008,18(3):115-119.
[9]	Goldstein DS,Holmes C,Cannon RO 3rd,et al.Sympathetic cardioneuropthy in dysautonomias.N Engl J Med,1997,336(10):696-702.
[10]	Schafers M,Lerch H,Wichter T,et al.Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia.J Am Coll Cardiol,1998,32(1):181-186.
[11]	Malfatto G,Branzi G,Ciambellotti F,et al.Different ventrieular remodelling and autonomic modulation after long-term betablocker treatment in hypertensive,ischaemic and idiopathic dilated cardiomyopathy.J Cardiovasc Med (Hngerstown),2007,8(10):840-845.
[12]	Li ST,Tack CJ,Fananapazir L,et al.Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy.J Am Coll Cardiol,2000,35(7):1867-1873.
[13]	Sasano T,Abraham MR,Chang KC,et al.Abnormal sympathetic innervatian of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction,J Am Coll Cardiol,2008,51(23):2266-2275.
[14]	John AS,Mongillo M,Depre C,et al.Pre-and post-synaptic sympathetic function in human hibernating myocardium.Eur J Nucl Med Mol Imaging,2007,34(12):1973-1980.
[15]	Bengel FM,Ueberfuhr P,Karja J,et al.Sympathetic reinnervation,exercise performance and effects of beta-adrenergic blockade in cardiac transplant recipients.Eur Heart J,2004,25(19):1726-1733.
[16]	Kusmic C,Morbelli S,Marini C,et al.Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type Ⅱ diabetes and its relationship with norepinephrine transport protein concentration.J Nucl Med,2008,49(10):1701-1706.
[17]	Jermendy G.Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients.Acta Diabetol,2003,40(Suppl 2):S370-S374.

[1]	张敏 , 何玉林 , 王相成 , 王雪梅 . ¹¹C标记的心脏交感神经受体显像剂的研究进展. 国际放射医学核医学杂志, 2023, 47(2): 105-111. doi: 10.3760/cma.j.cn121381-202208001-00274
[2]	曹京旭 , 王迎选 , 李志旺 . 放射损伤性心脏病. 国际放射医学核医学杂志, 1999, 23(2): 76-78.
[3]	宋建波 , 李思进 . 放射性心脏损伤临床研究进展. 国际放射医学核医学杂志, 2011, 35(2): 117-124. doi: 10.3760/cma.j.issn.1673-4114.2011.02.013
[4]	张照辉 , 贾廷珍 , 张淑兰 , 梁莉 , 马力文 , 毛节明 . 放射性心脏损伤诊断标准解读. 国际放射医学核医学杂志, 2012, 36(2): 117-120. doi: 10.3760/cma.j.issn.1673-4114.2012.02.015
[5]	王明贞 , 韩巍 , 付鹏 , 赵长久 . 靶向转位蛋白正电子示踪剂在神经炎症显像方面的应用. 国际放射医学核医学杂志, 2022, 46(12): 742-748. doi: 10.3760/cma.j.cn121381-202204032-00246
[6]	袁杰 , 刘兴党 , 韩梅 . SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用. 国际放射医学核医学杂志, 2013, 37(1): 30-33, 41. doi: 10.3760/cma.j.issn.1673-4114.2013.01.009
[7]	宋书扬 , 韩旭 , 汪蕾 , 闫朝武 , 方纬 . 核素心肌灌注/代谢显像与心脏磁共振成像评价缺血性心脏病心肌活力的对比研究. 国际放射医学核医学杂志, 2024, 48(1): 38-45. doi: 10.3760/cma.j.cn121381-202308010-00386
[8]	苏瑶 , 王丽 , 刘爱军 , 杨敏福 . Al¹⁸F-NOTA-FAPI PET/CT显像在轻链型心脏淀粉样变中的诊断价值. 国际放射医学核医学杂志, 2024, 48(1): 15-21. doi: 10.3760/cma.j.cn121381-202309001-00382
[9]	蔡琳婷 , 陈文新 . 心肌细胞葡萄糖转运蛋白4的转运调控及与心肌活力关系的研究进展. 国际放射医学核医学杂志, 2013, 37(1): 47-51. doi: 10.3760/cma.j.issn.1673-4114.2013.01.013
[10]	孙延睿 , 田强强 , 盛开 . ¹⁸F-FDG PET/CT显像在心脏肿瘤中的应用. 国际放射医学核医学杂志, 2020, 44(7): 453-458. doi: 10.3760/cma.j.cn121381-201907022-00045
[11]	张元丽 , 李慧敏 , 郭小闪 . 核医学显像在心脏淀粉样变性中的应用进展. 国际放射医学核医学杂志, 2023, 47(6): 372-377. doi: 10.3760/cma.j.cn121381-202208014-00308